Literature DB >> 3130767

Primary pulmonary hypertension in patients with classic hemophilia.

G H Goldsmith1, R G Baily, D B Brettler, W R Davidson, J O Ballard, T E Driscol, J M Greenberg, C K Kasper, P H Levine, O D Ratnoff.   

Abstract

Five patients with classic hemophilia were found to have primary pulmonary hypertension, a disorder not previously recognized in this population. All patients had had their coagulation disorder treated for 10 years or more with self-administered lyophilized concentrates of factor VIII, and all had antibodies to human immunodeficiency virus (HIV). Primary pulmonary hypertension was confirmed by histologic means at autopsy in one patient and by lung biopsy findings in another. In the other three patients, the findings are in agreement with this diagnosis. No patient had underlying cardiac or pulmonary disease, or clinical or pathologic evidence of collagen-vascular disease, vasculitis, parasitic disorders, hemoglobinopathy, or exposure to anorexigenic agents. Whether the primary pulmonary hypertension was related to treatment with lyophilized factor VIII, or to the presence of antibodies to HIV, or both, is unknown.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130767     DOI: 10.7326/0003-4819-108-6-797

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Effects of factor VIII concentrates on the immune system in hemophilic patients.

Authors:  S Schulman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Primary pulmonary hypertension and human immunodeficiency virus infection.

Authors:  J Conly; R Hilsden; H Deneer; I Etches; T Moyana
Journal:  Can J Infect Dis       Date:  1997-09

Review 3.  Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systems.

Authors:  M C Poon
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

Review 4.  Primary pulmonary hypertension associated with human immunodeficiency virus infection.

Authors:  R Golpe; B Fernandez-Infante; S Fernandez-Rozas
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.